Get the Stockscreener App
0.0288
93.33%
-0.4032
After Hours:
.01
-0.0188
-65.28%
Cell MedX Corp Stock (CMXC) Forecast
The Cell MedX Corp (CMXC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.2127, representing a +638.56% increase from the current price of $0.0288. The highest analyst price target is $0.2108, and the lowest is $0.2146.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CMXC Price Target
Average 0.2326
(+707.58% Upside)
Long-term CMXC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cell MedX Corp financial reports and earnings history, Cell MedX Corp (CMXC) stock could reach $0.4607 by 2030, $1.514 by 2040 and $2.8321 by 2050. See the projected annual prices until 2050 of the Cell MedX Corp stock below:
- Cell MedX Corp (CMXC) is expected to reach an average price of $1.3119 in 2035, with a high prediction of $1.4623 and a low estimate of $0.4727. This indicates an $4,455% rise from the last recorded price of $0.0288.
- Cell MedX Corp (CMXC) stock is projected to chart a bullish course in 2040, with an average price target of $1.245, representing an $4,223% surge from its current level. The forecast ranges from a conservative $1.245 to a sky-high $1.514.
- Our analysts predict Cell MedX Corp (CMXC) to jump 3,544% by 2045, soaring from $0.8842 to an average price of $1.0495, potentially reaching $1.2148. While $0.8842 is the low estimate, the potential upside is significant.
- Cell MedX Corp (CMXC) stock is expected to climb by 2050, reaching an average of $2.3709, a $8,132% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.8321 and $2.4144, respectively, highlighting the market's uncertainty.
Cell MedX Corp Stock (CMXC) Year by Year Forecast
Cell MedX Corp Stock (CMXC) Price Forecast for 2025
Cell MedX Corp Stock (CMXC) is expected to reach an average price of $0.1996 in 2025, with a high prediction of $0.3215 and a low estimate of $0.0777. This indicates an +592.90% rise from the last recorded price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $0.2024 | $0.2146 | $0.2108 | +602.80% |
| July, 2025 | $0.1212 | $0.1602 | $0.146 | +320.87% |
| August, 2025 | $0.1178 | $0.1139 | $0.1156 | +309.07% |
| September, 2025 | $0.0968 | $0.0988 | $0.1139 | +236.17% |
| October, 2025 | $0.2473 | $0.0941 | $0.3215 | +758.64% |
| November, 2025 | $0.2421 | $0.2543 | $0.2538 | +740.50% |
| December, 2025 | $0.147 | $0.147 | $0.184 | +410.36% |
Cell MedX Corp Stock (CMXC) Price Forecast for 2026
The predicted value for Cell MedX Corp (CMXC) in 2026 is set at an average of $0.2904. Estimates vary from a peak of $0.4703 to a trough of $0.1106, indicating an +908.38% surge from the present price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.139 | $0.142 | $0.142 | +382.50% |
| February, 2026 | $0.1149 | $0.1169 | $0.1311 | +299.08% |
| March, 2026 | $0.3164 | $0.1106 | $0.3711 | +998.68% |
| April, 2026 | $0.223 | $0.28 | $0.2967 | +674.34% |
| May, 2026 | $0.1784 | $0.1784 | $0.2081 | +519.29% |
| June, 2026 | $0.173 | $0.17 | $0.17 | +500.66% |
| July, 2026 | $0.1398 | $0.127 | $0.1525 | +385.31% |
| August, 2026 | $0.346 | $0.361 | $0.4207 | +1,101% |
| September, 2026 | $0.2629 | $0.3064 | $0.3181 | +812.98% |
| October, 2026 | $0.2422 | $0.2097 | $0.2319 | +740.83% |
| November, 2026 | $0.1739 | $0.1808 | $0.1981 | +503.94% |
| December, 2026 | $0.4749 | $0.1435 | $0.4703 | +1,549% |
Cell MedX Corp Stock (CMXC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cell MedX Corp (CMXC) is $0.3647, with a high forecast of $0.5695 and a low forecast of $0.16. This indicates an +1,166% increase from the last price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.3889 | $0.4057 | $0.4034 | +1,250% |
| February, 2027 | $0.2993 | $0.3428 | $0.3594 | +939.18% |
| March, 2027 | $0.2261 | $0.2261 | $0.2666 | +685.24% |
| April, 2027 | $0.1954 | $0.2022 | $0.2164 | +578.35% |
| May, 2027 | $0.4523 | $0.16 | $0.5199 | +1,471% |
| June, 2027 | $0.4258 | $0.4306 | $0.4324 | +1,378% |
| July, 2027 | $0.3112 | $0.3336 | $0.3959 | +980.71% |
| August, 2027 | $0.2498 | $0.2542 | $0.2864 | +767.44% |
| September, 2027 | $0.1987 | $0.2021 | $0.2376 | +589.88% |
| October, 2027 | $0.5003 | $0.1764 | $0.5695 | +1,637% |
| November, 2027 | $0.4404 | $0.4526 | $0.4787 | +1,429% |
| December, 2027 | $0.3194 | $0.3683 | $0.374 | +1,009% |
Cell MedX Corp Stock (CMXC) Price Forecast for 2028
In 2028, Cell MedX Corp (CMXC) is projected to reach an average price of $0.4308, with a high projection of $0.6687 and a low estimate of $0.1929. This indicates an +1,396% rise from the last price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2627 | $0.2717 | $0.3038 | +812.10% |
| February, 2028 | $0.2055 | $0.2075 | $0.2451 | +613.61% |
| March, 2028 | $0.525 | $0.1929 | $0.6191 | +1,723% |
| April, 2028 | $0.48 | $0.4922 | $0.5127 | +1,567% |
| May, 2028 | $0.3352 | $0.3352 | $0.412 | +1,064% |
| June, 2028 | $0.2874 | $0.2964 | $0.3122 | +898.01% |
| July, 2028 | $0.2388 | $0.2093 | $0.2682 | +729.11% |
| August, 2028 | $0.5842 | $0.5842 | $0.6687 | +1,928% |
| September, 2028 | $0.451 | $0.508 | $0.5546 | +1,466% |
| October, 2028 | $0.3907 | $0.3666 | $0.4262 | +1,257% |
| November, 2028 | $0.3115 | $0.3163 | $0.3384 | +981.66% |
| December, 2028 | $0.2534 | $0.2258 | $0.2811 | +780.01% |
Cell MedX Corp Stock (CMXC) Price Forecast for 2029
The 2029 price forecast for Cell MedX Corp Stock (CMXC) is $0.5299 on average, with a high prediction of $0.8175 and a low estimate of $0.2423. This represents an +1,740% increase from the previous price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6038 | $0.6208 | $0.7183 | +1,997% |
| February, 2029 | $0.481 | $0.5245 | $0.566 | +1,570% |
| March, 2029 | $0.4205 | $0.398 | $0.44 | +1,360% |
| April, 2029 | $0.3025 | $0.3094 | $0.3664 | +950.41% |
| May, 2029 | $0.7725 | $0.2423 | $0.7679 | +2,582% |
| June, 2029 | $0.6468 | $0.6638 | $0.691 | +2,146% |
| July, 2029 | $0.4847 | $0.5071 | $0.6073 | +1,583% |
| August, 2029 | $0.3945 | $0.3945 | $0.4515 | +1,270% |
| September, 2029 | $0.3239 | $0.3308 | $0.3748 | +1,025% |
| October, 2029 | $0.74 | $0.2587 | $0.8175 | +2,469% |
| November, 2029 | $0.6737 | $0.6785 | $0.7101 | +2,239% |
| December, 2029 | $0.4845 | $0.5343 | $0.6338 | +1,582% |
Cell MedX Corp Stock (CMXC) Price Forecast for 2030
Cell MedX Corp Stock (CMXC) is expected to reach an average price of $0.5959 in 2030, with a high forecast of $0.9167 and a low forecast of $0.2752. This signifies an +1,969% surge from the last price of $0.0288.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4082 | $0.4148 | $0.4607 | +1,317% |
| February, 2030 | $0.3173 | $0.3207 | $0.3861 | +1,002% |
| March, 2030 | $0.7879 | $0.2752 | $0.8671 | +2,636% |
| April, 2030 | $0.6783 | $0.6905 | $0.7564 | +2,255% |
| May, 2030 | $0.5176 | $0.5674 | $0.602 | +1,697% |
| June, 2030 | $0.4346 | $0.4412 | $0.4921 | +1,409% |
| July, 2030 | $0.3142 | $0.3162 | $0.4108 | +991.04% |
| August, 2030 | $0.8027 | $0.2916 | $0.9167 | +2,687% |
| September, 2030 | $0.641 | $0.698 | $0.7804 | +2,126% |
| October, 2030 | $0.5235 | $0.5235 | $0.6079 | +1,718% |
| November, 2030 | $0.4359 | $0.4449 | $0.4905 | +1,414% |
| December, 2030 | $0.3574 | $0.3081 | $0.4068 | +1,141% |
6.67%
10.73%
Cap:
|
Volume (24h):